These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 17967585)

  • 1. New antiarrhythmic drugs for establishing sinus rhythm in atrial fibrillation: what are our therapies likely to be by 2010 and beyond?
    Morrow JP; Cannon CP; Reiffel JA
    Am Heart J; 2007 Nov; 154(5):824-9. PubMed ID: 17967585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Restoration and maintenance of sinus rhythm in patients with atrial fibrillation. New pharmacological approaches].
    Runge S; Dietz R; Haverkamp W
    Dtsch Med Wochenschr; 2008 Dec; 133(49):2572-8. PubMed ID: 19039713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of contemporary antiarrhythmic drug therapy for maintenance of sinus rhythm in atrial fibrillation.
    Singla S; Karam P; Deshmukh AJ; Mehta J; Paydak H
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):12-20. PubMed ID: 21335483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
    Piccini JP; Hasselblad V; Peterson ED; Washam JB; Califf RM; Kong DF
    J Am Coll Cardiol; 2009 Sep; 54(12):1089-95. PubMed ID: 19744618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous amiodarone for conversion of atrial fibrillation: misled by meta-analysis?
    Slavik RS; Zed PJ
    Pharmacotherapy; 2004 Jun; 24(6):792-8. PubMed ID: 15222670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
    Wegener FT; Ehrlich JR; Hohnloser SH
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
    Pamukcu B; Lip GY
    Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.
    Pamukcu B; Lip GY
    Expert Opin Pharmacother; 2011 Jan; 12(1):131-40. PubMed ID: 21126199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dronedarone: an emerging therapy for atrial fibrillation.
    Rosei EA; Salvetti M
    Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):155-64. PubMed ID: 20418270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is oral sotalol effective in converting atrial fibrillation to sinus rhythm?
    Ferreira E; Sunderji R; Gin K
    Pharmacotherapy; 1997; 17(6):1233-7. PubMed ID: 9399605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dronedarone.
    Patel C; Yan GX; Kowey PR
    Circulation; 2009 Aug; 120(7):636-44. PubMed ID: 19687370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations.
    Singh BN
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):31S-5S. PubMed ID: 21098417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dronedarone: an overview.
    Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
    Ann Med; 2012 Feb; 44(1):60-72. PubMed ID: 21745093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.
    Garcia D; Cheng-Lai A
    Cardiol Rev; 2009; 17(5):230-4. PubMed ID: 19690474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dronedarone: current evidence and future questions.
    Schafer JA; Kjesbo NK; Gleason PP
    Cardiovasc Ther; 2010; 28(1):38-47. PubMed ID: 20074258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of atrial fibrillation.
    Hersi A; Wyse DG
    Curr Probl Cardiol; 2005 Apr; 30(4):175-233. PubMed ID: 15778690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic approaches to rhythm versus rate control in atrial fibrillation--where are we now?
    Wyse DG
    Int J Cardiol; 2006 Jun; 110(3):301-12. PubMed ID: 16516313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug therapy for atrial fibrillation.
    Musco S; Conway EL; Kowey PR
    Med Clin North Am; 2008 Jan; 92(1):121-41, xi. PubMed ID: 18061001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic drugs for atrial fibrillation.
    Marinelli A; Capucci A
    Expert Opin Pharmacother; 2011 Jun; 12(8):1201-15. PubMed ID: 21323608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.